Background
==========

Coronary heart disease (CHD) still remains the largest single cause of death and a major cause of morbidity in most developed countries \[[@B1]\]. Although rates of myocardial infarction have fallen in most developed countries, hospital admission rates for CHD have continued to rise \[[@B2],[@B3]\]. The treatment of CHD has meanwhile evolved, first with the widespread uptake of effective short and long-term medical treatment \[[@B4]\] and then with greater use of coronary artery revascularisation procedures (CARPs) \[[@B3],[@B4]\] which started with coronary artery bypass grafting (CABG) during the 1970s and evolved with percutaneous coronary interventions (PCI) with the introduction and rapid use of percutaneous transluminal coronary angioplasty in the early 1980s, coronary artery stents in 1995 and more recently drug eluting stents \[[@B5]\]. The use of stents has contributed to a decline in the risk of a repeat CARP following PCI \[[@B5]\] while drug-eluting stents may lead to further reductions in these risks \[[@B6],[@B7]\]. Based on several randomized controlled trials, CARPs are more effective than medical treatment in reducing mortality and morbidity from CHD \[[@B8],[@B9]\].

There is great variation in rates of CARPs within and between populations with comparable rates of CHD \[[@B10],[@B11]\]. Because of this uncertainty it is important to develop probabilistic methods that model the requirements for CARPs at the population level by capturing movement of individuals from one CHD/CARP state to another based on the epidemiology and natural history of CHD. This can be modelled by using Markov Monte Carlo simulation.

This study is facilitated by the availability of a unique Western Australian health information system which allows identification and linkage of hospital admission and deaths records pertaining to single individuals, thereby providing a complete event history for CHD patients \[[@B12]\]. In a previous paper we have described and outlined the use of a Markov Monte Carlo simulation model for predicting CHD incidence and requirements for CARPs for the Western Australian population \[[@B13]\]. In this paper, we expand on the use of this model for forecasting CARPs in Western Australia with a focus on how the standard model may be adapted to achieve better forecasting performance if anticipated changes are incorporated. The 1995 Western Australian population cohort is used to illustrate this approach with comparison of the predicted and actual numbers of CARPs performed over the period 1995 to 1999.

Methods
=======

Statewide datasets comprising (linked) cardiovascular hospital admissions for all persons who had a cardiovascular-related admission for the period 1980 to 2001 together with all deaths and population census information were used to establish CHD/CARP event history for population cohorts and estimate (population) probabilities of certain CHD and CARP events and deaths \[[@B13]\].

Under the Markov Monte Carlo simulation approach, for the cohort comprising the population of Western Australia aged 35--79 years at the beginning of 1995, model simulations are conducted to predict the number of CARPs (and other CHD events) that occur within the cohort over the next 5 years. Under our Markov model the cohort is split into initial history state groups (using their known CHD/CARP history from the linked health information system data back to 1980). The history states are (1) a history of having a PCI some time in the past; (2) a history of having a CABG some time in the past; (3) a history of having a CHD admission but no CABG or PCI some time in the past; and (4) no history of CHD admission, CABG or PCI in the past. In the context of forecasting, population transition probabilities that have been estimated for past years (eg 1992 to 1994) are extrapolated into future years for which forecasts are required (eg 1995 to 1999). These extrapolated probabilities are used within the model to simulate events among cohort members into the future (and taking into account the ageing of the cohort). At the end of the first cycle people could have moved to a different disease history state or moved into one of two possible death (absorbing) states, namely (5) death from CHD or (6) death from causes other than CHD. Within a cycle, our model allows for a CHD admission without a CARP, up to two admissions with CABG or PCI in addition to possible death (Figure [1](#F1){ref-type="fig"}). A more detailed description of the model and the estimation of population transition probabilities have been provided elsewhere \[[@B13]\].

![Schematic diagram for the recognised events during a cycle (year).](1472-6947-8-27-1){#F1}

For extrapolating transition probabilities two standard methods were used. These are (for each age, sex and history group) using the mean of the probabilities for the last three years (the mean method) and using linear extrapolation of transition probabilities based on the (weighted) annual changes over the last three years with twice as much weight assigned to the most recent annual change (the linear method). The mean extrapolation method is expected to perform well in situations when the (absolute) level of the probabilities remains fairly constant into the future and the linear extrapolation method is expected to perform well in situations when the probabilities are changing and are expected to continue to change at approximately the same rate. Modified extrapolation methods are obtained by modifying selected key probabilities of CARP events and adopting the standard extrapolation probabilities for the rest of the model probabilities.

The forecast number of events is based on the average of 100 replicate simulations of the entire cohort \[[@B13]\]. The accuracy of the total forecast number of CABGs and PCIs is evaluated using the percent over- or under- compared to the total actual number. The accuracy of forecasts across age and sex groups is evaluated by calculating a goodness-of-fit (GOF) observed-predicted chi-squared statistic. The smaller the GOF statistic the better are the model forecasts. We used SAS version 9.0 \[[@B14]\] for calculating the simulation inputs and TreeAge Data Pro 2005 for Markov simulation modelling \[[@B15]\].

No ethical approval was required for the project as the data for this project were already provided to the researchers by the Data Linkage Unit of the WA Department of Health.

Results
=======

Table [1](#T1){ref-type="table"} shows the number and history distribution of the WA 1995 population cohort. Overall 93.1% of men and 96.1% of women were in the \'no history of CHD\' state but this varied from 99.2% in 35--39 year old men to 76.2% in 75--79 year old men and from 99.6% in 35--39 year women to 84.6% in 75--79 year old women.

###### 

Age and sex distribution of the population of Western Australia for 1995

  Sex      Age group   Hist no CHD   Hist CHD   Hist CABG   Hist PCI   Total Population
  -------- ----------- ------------- ---------- ----------- ---------- ------------------
  Male     35--39      70144         461        28          52         70685
  Male     40--44      66197         818        100         142        67257
  Male     45--49      61080         1290       294         314        62978
  Male     50--54      44866         1689       506         445        47506
  Male     55--59      34500         2048       779         563        37890
  Male     60--64      27557         2522       1092        585        31756
  Male     65--69      23852         2930       1309        576        28667
  Male     70--74      17646         3097       1184        398        22325
  Male     75--79      10297         2345       667         206        13515
                                                                       
  Female   35--39      70024         301        6           4          70335
  Female   40--44      66195         472        16          19         66702
  Female   45--49      58333         632        29          46         59040
  Female   50--54      42960         937        60          84         44041
  Female   55--59      34614         1265       130         119        36128
  Female   60--64      29418         1592       204         169        31383
  Female   65--69      26848         2073       388         261        29570
  Female   70--74      22407         2610       431         250        25698
  Female   75--79      15694         2380       326         156        18556

Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} show the actual and forecast number of CABGs and PCIs respectively for the standard models. The results show that the mean method overestimates the total actual number of CABGs by 20.5 percent and the linear method by 15.6 percent. The GOF values are reasonably close for the two methods. The forecast numbers of PCIs from the mean method under-estimates the actual number of PCIs by 15.3 percent and the linear method over-estimates by 17.7 percent. The GOF value is considerably larger for the mean method.

###### 

Comparison between actual numbers of CABGs and forecast numbers (1995--1999) based on the standard Mean and Linear extrapolation methods as well as selected modifications of these methods

  Sex                     Age Group   Actual   Forecast under mean method   Forecast under modified mean method (Model 1)   Forecast under further modified mean method (Model 2)   Forecast under final modified mean method (Model 5)   Forecast under linear method   Forecast under modified linear method (Model 3)   Forecast under further modified linear method (Model 4)
  ----------------------- ----------- -------- ---------------------------- ----------------------------------------------- ------------------------------------------------------- ----------------------------------------------------- ------------------------------ ------------------------------------------------- ---------------------------------------------------------
  Male                    35--39      90       113                          115                                             110                                                     98                                                    127                            124                                               122
  Male                    40--44      206      271                          278                                             265                                                     239                                                   271                            266                                               262
  Male                    45--49      394      535                          533                                             528                                                     470                                                   512                            512                                               495
  Male                    50--54      601      733                          730                                             719                                                     637                                                   697                            696                                               678
  Male                    55--59      759      892                          892                                             883                                                     778                                                   862                            862                                               844
  Male                    60--64      829      1035                         1028                                            1025                                                    896                                                   1009                           1013                                              1007
  Male                    65--69      950      1075                         1066                                            1065                                                    930                                                   1088                           1078                                              1080
  Male                    70--74      678      771                          773                                             769                                                     667                                                   810                            808                                               810
  Male                    75--79      245      309                          306                                             307                                                     264                                                   361                            359                                               360
  Male                    All         4752     5734                         5721                                            5671                                                    4979                                                  5737                           5718                                              5658
                                                                                                                                                                                                                                                                                                                           
  Female                  35--39      22       16                           18                                              15                                                      15                                                    14                             15                                                15
  Female                  40--44      40       38                           41                                              38                                                      36                                                    37                             40                                                38
  Female                  45--49      49       82                           85                                              72                                                      76                                                    70                             70                                                69
  Female                  50--54      108      137                          143                                             125                                                     128                                                   126                            127                                               123
  Female                  55--59      152      216                          224                                             213                                                     200                                                   200                            199                                               197
  Female                  60--64      262      305                          324                                             302                                                     281                                                   242                            243                                               239
  Female                  65--69      319      392                          417                                             387                                                     362                                                   283                            284                                               276
  Female                  70--74      302      341                          363                                             336                                                     313                                                   264                            267                                               263
  Female                  75--79      151      161                          169                                             161                                                     145                                                   145                            144                                               142
  Female                  All         1405     1688                         1784                                            1649                                                    1556                                                  1381                           1389                                              1362
                                                                                                                                                                                                                                                                                                                           
  Total                               6157     7422                         7505                                            7320                                                    6535                                                  7118                           7107                                              6744
                                                                                                                                                                                                                                                                                                                           
  \% change from actual                        20.5                         21.9                                            18.9                                                    6.1                                                   15.6                           15.4                                              9.5
                                                                                                                                                                                                                                                                                                                           
  GOF                                          246.52                       272.87                                          212.55                                                  61.96                                                 224.65                         215.30                                            200.18

###### 

Comparison between actual numbers of PCIs and forecast numbers (1995--1999) based on the standard Mean and Linear extrapolation methods as well as selected modifications of these

  Sex                     Age Group   Actual PCI   Forecast under mean method   Forecast under modified mean method (Model 1)   Forecast under further modified mean method (Model 2)   Forecast under final modified mean method (Model 5)   Forecast under linear method   Forecast under modified linear method (Model 3)   Forecast under further modified linear method (Model 4)
  ----------------------- ----------- ------------ ---------------------------- ----------------------------------------------- ------------------------------------------------------- ----------------------------------------------------- ------------------------------ ------------------------------------------------- ---------------------------------------------------------
  Male                    35--39      233          204                          210                                             190                                                     236                                                   251                            243                                               241
  Male                    40--44      412          423                          424                                             401                                                     492                                                   554                            527                                               526
  Male                    45--49      730          697                          696                                             659                                                     817                                                   934                            889                                               893
  Male                    50--54      788          800                          807                                             754                                                     917                                                   1032                           1008                                              1014
  Male                    55--59      909          819                          824                                             779                                                     950                                                   1084                           1013                                              1014
  Male                    60--64      888          762                          767                                             717                                                     880                                                   1069                           994                                               994
  Male                    65--69      878          662                          665                                             632                                                     769                                                   1064                           988                                               991
  Male                    70--74      716          414                          417                                             393                                                     477                                                   745                            694                                               698
  Male                    75--79      260          153                          153                                             146                                                     177                                                   261                            259                                               262
  Male                    All         5814         4934                         4963                                            4671                                                    5715                                                  6994                           6615                                              6633
                                                                                                                                                                                                                                                                                                                               
  Female                  35--39      24           19                           21                                              20                                                      23                                                    26                             26                                                25
  Female                  40--44      81           61                           63                                              64                                                      69                                                    58                             56                                                56
  Female                  45--49      119          134                          136                                             138                                                     148                                                   135                            129                                               128
  Female                  50--54      189          178                          185                                             213                                                     201                                                   215                            199                                               199
  Female                  55--59      250          221                          230                                             222                                                     249                                                   285                            262                                               260
  Female                  60--64      338          279                          289                                             281                                                     315                                                   341                            324                                               319
  Female                  65--69      381          326                          339                                             329                                                     364                                                   436                            411                                               414
  Female                  70--74      348          274                          284                                             258                                                     293                                                   397                            377                                               375
  Female                  75--79      197          129                          136                                             122                                                     134                                                   219                            205                                               205
  Female                  All         1927         1621                         1683                                            1647                                                    1796                                                  2112                           1989                                              1981
                                                                                                                                                                                                                                                                                                                               
  Total                               7741         6555                         6646                                            6318                                                    7511                                                  9106                           8604                                              8614
                                                                                                                                                                                                                                                                                                                               
  \% change from actual                            -15.3                        -14.1                                           -18.4                                                   -3.0                                                  17.6                           11.1                                              11.3
                                                                                                                                                                                                                                                                                                                               
  GOF                                              494.11                       455.09                                          643.38                                                  265.37                                                265.03                         155.37                                            159.38

The poor performance of these standard methods for forecasting the requirements of CARPs over 1995--99 may be due to the fact that the effectiveness of PCIs increased after 1994 when stents were first introduced in WA and as a result the probability of requiring another CARP within the same year was reduced. Within the model these are represented by risk of a CABG or another PCI in the same year following a PCI procedure. For both males and females, the trends in these probabilities for the largest history group \'no history of CHD\' are shown in Figures [2a, 2b](#F2){ref-type="fig"}, [3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"}. It is clear that the trend over the period 1992 to 1994 did not continue into 1995--1999 and hence the standard extrapolation methods would not be accurate for these probabilities.

![**a.** Plot for risk of CABG within same year following a PCI, for people with no history of CHD by calendar year, for males with different age groups. **b.** Plot for risk of CABG within same year following a PCI, for people with no history of CHD by calendar year, for females with different age groups](1472-6947-8-27-2){#F2}

![**a.** Plot for risk of a repeat PCI within same year, for people with no history of CHD by calendar years, for males with different age groups. **b.** Plot for risk of a repeat PCI within same year, for people with no history of CHD by calendar years, for females with different age groups](1472-6947-8-27-3){#F3}

Another explanation for the poor performance of the standard methods was that there was an increasing trend in PCI rates during the early 1990s as the number of facilities performing PCIs increased and this continued until about 1995 \[[@B6]\]. This, together with the increasing effectiveness of PCIs meant that many more PCIs but fewer CABGs were being performed. Within the model these are captured by risk of a CABG and risk of a PCI. For both sexes, the trends in these risks for the \'no CHD history\' group are shown in Figures [4a, 4b](#F4){ref-type="fig"}, [5a](#F5){ref-type="fig"} and [5b](#F5){ref-type="fig"}. It is clear that the risk of a CABG and that of a PCI gradually declined and increased respectively after 1994 for most age groups 50--54 and above (the trends for younger age groups are not shown as these risks are low), for both sexes.

![**a.** Plot for risk of a CABG within a year, for people with no history of CHD by calendar year, for males with different age groups. **b.** Plot for risk of a CABG within a year, for people with no history of CHD by calendar year, for females with different age groups](1472-6947-8-27-4){#F4}

![**a.** Plot for risk of a PCI, for people with no history of CHD by calendar year, for males with different age groups. **b.** Plot for risk of a PCI, for people with no history of CHD by calendar year, for females with different age groups](1472-6947-8-27-5){#F5}

In order to incorporate modifications to the standard extrapolation methods relating to the increased effectiveness of PCI procedures (ie the decreased risk of requiring a second CARP within the same year) we have examined the clinical trial evidence for the improved effectiveness of PCIs with stents. The results of a meta-analysis of 29 RCTs by Brophy et al. \[[@B16]\] indicate that risk of a repeat PCI would have declined by 41 percent in Western Australia from 1995 due to the introduction of stents. The observed risks for the Western Australian population showed that the risk of a CABG after a PCI also declined by 41 percent and thus we also reduce this risk accordingly.

To quantify the changed trends for PCI and CABG rates we use evidence from a population based observational study in Western Australia which showed that for males risk of a PCI increased by about 25 percent and risk of a CABG declined by about 15 percent when stents were introduced in WA in 1995 \[[@B5]\]. For females, there were similar shifts but the magnitude was about half that in males.

To accommodate these changed trends we have modified the standard extrapolated probabilities for these events by the amounts indicated by the evidence. Forecasts based on the following modified models have been obtained and the results are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

**Model 1**: the annual risk of a repeat PCI declines by 41 percent while the other risks are mean extrapolated,

**Model 2**: the annual risk of a repeat PCI and risk of a CABG given PCI decline by 41 percent while the other risks are mean extrapolated,

**Model 3**: the annual risk of a repeat PCI declines by 41 percent while the other risks are linearly extrapolated,

**Model 4**: the annual risk of a repeat PCI and risk of a CABG given PCI decline by 41 percent while the other risks are linearly extrapolated, and

**Model 5**: the annual risk of a repeat PCI and risk of a CABG given PCI decline by 41 percent and risk of a PCI increases by 25 percent for males or 12.5 percent for females with a corresponding decline in risk of a CABG by 15 percent for males or 7.5 percent for females while the other risks are mean extrapolated.

The results show that the forecast numbers of PCIs under Model 1 become closer to the respective actual numbers compared to standard mean extrapolation although the discrepancies are still generally quite large. Also, this modification does not improve the forecasts for CABGs. The forecasts for numbers of CABGs and PCIs under Models 2, 3 and 4 improve only marginally. There is over-estimation in the actual number of CABGs by 21.9, 18.9, 15.4 and 9.5 percents respectively under Models 1, 2, 3 and 4. There is under-estimation in the actual number of PCIs by 14.1 and 18.4 percents respectively under Models 1 and 2, and over-estimation by 11.1 and 11.3 percents under Models 3 and 4.

As the forecasts under Model 3 which use linear extrapolations seriously overestimated the numbers of PCIs the linear method was not further considered. Model 5, which also incorporates modifications to risk of a PCI and risk of a CABG has considerably better forecasts. There is now only 6.1 percent over-estimation of number of CABGs under Model 5 while for PCIs there is an under-estimation by only 3 percent.

Discussion
==========

In this paper we have examined forecasts for 1995--1999 based on extrapolation of trends from 1992--94. This was done because actual event numbers were known for these years and to illustrate the need to modify the standard methods in a period like this when there were rapid changes in CARP surgical technology and practice. However, the limitations of the retrospective nature of this study should be acknowledged. We believe that the modifications could have been anticipated in 1995 when knowledge of increased PCI effectiveness was becoming available and the changing preference for PCI over CABG was common knowledge among cardiologists and cardio-thoracic surgeons. However, quantifying the impacts of these expected changes in 1995 would have been more difficult than in our illustration which used evidence published after 1995.

Our CHD/CARP model does not directly incorporate the effects of risk factors such as blood pressure, cholesterol, obesity and smoking on event risks. Whilst cohort-based models that incorporate risk factors have been proposed (eg, Sesso et al. \[[@B17]\]) it is not practical to incorporate risk factors directly into our model because it has 96 different risks (for each age and sex group) and thus 96 risk factor models would be required. Further, as our model simulates individual pathways, such an approach would also require risk factor data on the entire population of Western Australia. However, our model can still indirectly incorporate changes in trends in risk factors by appropriate modification of model probabilities that relate to risk of certain CHD events (eg for people currently with no history of CHD).

Using the approach of modifying selected and relevant model event probabilities, our model is flexible enough to explore the effect on the future requirements of CARPs of a variety of changing circumstances. In addition to advances in surgical procedures and changing preference for surgical procedures as we have illustrated, other scenarios such as changes in the effectiveness of, and access to, medical treatments may be investigated. For example, randomized controlled trials have shown that there were significant reductions in requirements for CARPs among higher risk individuals who were given antiplatelet therapy versus controls \[[@B18]\]. An example of a possible change in health policy related to treating CHD patients could be the availability of low cost statins \[[@B19]\]. Since the cost of the Australian Pharmaceutical Benefit Scheme which subsidizes the cost of statin drugs has been increasing rapidly, the government may change its current policy and only provide subsidy to people at higher risk of CHD. The effect of these changes relating to medical treatments could be investigated using our CHD/CARP model through modifications to selected and relevant model probabilities.

The CHD/CARP model can also be extended and used to determine the cost of future requirements for CARPs and to explore the most cost-effective strategies for treatment of CHD. To achieve this, indicative cost estimates are needed for each of the alternative CARP treatments for each year. For more description of cost effectiveness analysis one can refer to some studies which have evaluated economic impact of drug-eluting stents \[[@B20],[@B21]\], and cost effectiveness of CHD prevention through CHD risk reduction strategies \[[@B22]\].

Conclusion
==========

It is clear from the model simulation results that forecasting events in an era of rapid changes is fraught with difficulties and standard extrapolation methods are not likely to perform well in such situations. However, there is often knowledge and sometimes quantitative evidence of the expected impacts of changes in procedure effectiveness and practice and these may be used to modify the standard forecasting methods to achieve better forecasts as we have illustrated. The simulation results implied that modifications that related to the changing relative use of a PCI to a CABG were more important for correctly projecting the numbers of CARPs than modifications that related only to the increased effectiveness of PCI procedures.
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